Market By Age Group, Education, Drugs & Devices And End Users | Forecasts 2019-2027
According to Triton Market Research’s report, the Middle East & African contraceptives market is expected to expand at a CAGR of 6.67% during the forecast years 2019-2027.
The countries covered in the Middle East & African region are:
O Saudi Arabia
O Turkey
O The UAE
O South Africa
O rest of the Middle East & Africa
The major reasons for the growing popularity of contraceptives in the Middle East & African market are the irrational use of oral contraceptives by women, especially in Saudi Arabia. These oral pills are used to adjourn menstrual periods for a number of reasons. The economic development scenario in the MEA region is unbalanced.
However, South Africa shows considerable socio-economic development. The South African health minister, in 2014, announced that all public healthcare facilities would offer free contraceptives and make them widely accessible. The national governments in these regions need to increase investments made for birth control awareness programs and strengthen policies to increase the adoption of contraceptives. Introduction of contraception methods and raising awareness levels of the population will go a long way in propelling market growth. Barriers such as high costs and limited access to contraception techniques are the key restraints faced by the market.
The Middle East & African contraceptives market can be compartmentalized based on education, age groups, end users and drugs and devices. Oral pills and injectables are the majorly used forms of contraception used by Africans.
Technologically advanced contraceptives are highly effective and are also safe and reliable to use. Additionally, the improved incomes of the population help create demand for these products. In countries such as Turkey, the male populace is reluctant to make use of contraceptives due to the desire to reproduce until the birth of a son or many sons. This is a major challenge faced by the market in the MEA region.
The various companies engaged in the development of contraceptives are Okamoto Industries, Inc., SMB Corporation, Afaxys, Inc., Ocon Medical, Ltd., Mayer Laboratories, Inc., Church & Dwight Co., Inc., Agile Therapeutics, Reckitt Benckiser PLC, Pfizer, Inc., Melbea, Bayer AG, Allergan, Inc., Teva Pharmaceutical Industries, Ltd., Pregna, Apothecus Pharmaceutical Corporation, Cooper Surgical, Inc. and Merck & Co., Inc.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. CONTRACEPTIVE
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. REGULATORY
OUTLOOK
2.4. PESTEL
OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. MARKET
PLAYER POSITIONING
2.7. KEY
INSIGHTS
2.7.1. ORAL
CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS
2.7.2. CONDOMS
ARE THE WIDELY USED CONTRACEPTIVES DEVICE
2.7.3. AGE
GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE CONTRACEPTIVE
MARKET
2.8. MARKET
DRIVERS
2.8.1. GROWING
COGNIZANCE FOR CONTRACEPTIVES
2.8.2. INCREASING
USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY
2.8.3. SURGE
IN THE INITIATIVES OF GOVERNMENT AND NGO
2.8.4. GROWING
AWARENESS ABOUT STD
2.9. MARKET
RESTRAINTS
2.9.1. SIDE
EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES
2.9.2. LIMITED
ACCESS TO CONTRACEPTIVES
2.10.
MARKET OPPORTUNITIES
2.10.1.
RISING DISPOSABLE INCOME IN
EMERGING ECONOMIES
2.10.2.
UNMET MEDICAL NEEDS IN THE
EMERGING ECONOMIES
2.10.3.
TECHNOLOGICAL ADVANCEMENTS
2.11.
MARKET CHALLENGES
2.11.1.
LACK OF ACCEPTANCE OF SOCIETY
3. CONTRACEPTIVE
MARKET OUTLOOK - BY EDUCATION
3.1. LESS
THAN HIGH SCHOOL
3.2. HIGH
SCHOOL GRADUATE
3.3. COLLEGE
GRADUATE
3.4. OTHER
COLLEGE DEGREES
4. CONTRACEPTIVE
MARKET OUTLOOK - BY AGE GROUP
4.1. 15–24
YEARS
4.2. 25–34
YEARS
4.3. 35–44
YEARS
4.4. ABOVE
44 YEARS
5. CONTRACEPTIVE
MARKET OUTLOOK - BY END USER
5.1. HOUSEHOLDS
5.2. CLINICS
5.3. HOSPITALS
6. CONTRACEPTIVE
MARKET OUTLOOK - BY DRUGS AND DEVICES
6.1. CONTRACEPTIVES
DRUGS
6.1.1. ORAL
CONTRACEPTIVE PILLS
6.1.2. INJECTABLE
CONTRACEPTIVES
6.1.3. TOPICAL
CONTRACEPTIVES
6.2. CONTRACEPTIVE
DEVICES
6.2.1. MALE
CONDOMS
6.2.2. FEMALE
CONDOMS
6.2.3. DIAPHRAGMS
6.2.4. CONTRACEPTIVE
SPONGES
6.2.5. VAGINAL
RINGS
6.2.6. SUBDERMAL
IMPLANTS
6.2.7. INTRA-UTERINE
DEVICES
6.2.7.1. COPPER
INTRA-UTERINE DEVICES
6.2.7.2. HORMONAL
INTRA-UTERINE DEVICES
7. CONTRACEPTIVE
MARKET - REGIONAL OUTLOOK
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. UNITED
ARAB EMIRATES
7.1.1.2. TURKEY
7.1.1.3. SAUDI
ARABIA
7.1.1.4. SOUTH
AFRICA
7.1.1.5. REST
OF THE MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. COMPANY
PROFILES
8.1.1. ALLERGAN
INC.
8.1.2. BAYER
AG
8.1.3. MELBEA
8.1.4. PREGNA
8.1.5. PFIZER,
INC.
8.1.6. CHURCH
& DWIGHT CO., INC.
8.1.7. AFAXYS,
INC.
8.1.8. APOTHECUS
PHARMACEUTICAL CORPORATION
8.1.9. COOPER
SURGICAL INC
8.1.10.
OKAMOTO INDUSTRIES, INC
8.1.11.
MAYER LABORATORIES, INC.
8.1.12.
AGILE THERAPEUTICS
8.1.13.
MERCK & CO., INC.
8.1.14.
RECKITT BENCKISER PLC
8.1.15.
SMB CORPORATION
8.1.16.
TEVA PHARMACEUTICAL INDUSTRIES
LTD.
8.1.17.
OCON MEDICAL LTD
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET 2019-2027 ($ MILLION)
TABLE 2 CONTRACEPTIVE MARKET PLAYER POSITIONING OUTLOOK 2017
TABLE 3 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY EDUCATION 2019-2027 ($ MILLION)
TABLE 4 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY AGE GROUP 2019-2027 ($ MILLION)
TABLE 5 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 6 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 7 THE MIDDLE EAST AND AFRICA
CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 8 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 9 THE MIDDLE EAST AND AFRICA INTRA-UTERINE
DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 10 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET 2019-2027 ($ MILLION)
FIGURE 2 PORTER’S FIVE FORCE MODEL
FIGURE 3 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET
BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)
FIGURE 4 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)
FIGURE 5 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)
FIGURE 6 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET
BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)
FIGURE 7 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)
FIGURE 8 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)
FIGURE 9 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)
FIGURE 10 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)
FIGURE 11 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)
FIGURE 12 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY CLINICS 2019-2027 ($ MILLION)
FIGURE 13 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 14 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)
FIGURE 15 THE MIDDLE EAST AND AFRICA CONTRACEPTIVES
DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)
FIGURE 16 THE MIDDLE EAST AND AFRICA CONTRACEPTIVES
DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 17 THE MIDDLE EAST AND AFRICA CONTRACEPTIVES
DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 18 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)
FIGURE 19 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 20 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE DEVICES
MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 21 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)
FIGURE 22 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)
FIGURE 23 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)
FIGURE 24 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)
FIGURE 25 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 26 THE MIDDLE EAST AND AFRICA INTRA-UTERINE
DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 27 THE MIDDLE EAST AND AFRICA INTRA-UTERINE
DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 28 UNITED ARAB EMIRATES CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 29 TURKEY CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 30 SAUDI ARABIA CONTRACEPTIVE MARKET 2019-2027
($ MILLION)
FIGURE 31 SOUTH AFRICA CONTRACEPTIVE MARKET 2019-2027
($ MILLION)
FIGURE 32 REST OF THE MIDDLE EAST AND AFRICA
CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)